Technologies
Cartesian Therapeutics Inc (NASDAQ:RNAC) Drops -31.99% In 2025; Is It Affordable At $10.00?
In last trading session, Cartesian Therapeutics Inc (NASDAQ:RNAC) saw 0.34 million shares changing hands with its beta currently measuring 0.50. Company’s recent per share price
